SAI LIFE SCIENCES LTD

NSE:SAILIFE India Diagnostics & Research
Market Cap
$2.48 Billion
₹214.70 Billion INR
Market Cap Rank
#7180 Global
#265 in India
Share Price
₹1013.85
Change (1 day)
+2.81%
52-Week Range
₹716.65 - ₹1069.20
All Time High
₹1069.20
About

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was … Read more

SAI LIFE SCIENCES LTD - Asset Resilience Ratio

Latest as of March 2025: 8.90%

SAI LIFE SCIENCES LTD (SAILIFE) has an Asset Resilience Ratio of 8.90% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹2.81 Billion
Cash + Short-term Investments
Total Assets
₹31.60 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how SAI LIFE SCIENCES LTD's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down SAI LIFE SCIENCES LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹0.00 0%
Short-term Investments ₹2.81 Billion 8.9%
Total Liquid Assets ₹2.81 Billion 8.90%

Asset Resilience Insights

  • Limited Liquidity: SAI LIFE SCIENCES LTD maintains only 8.90% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

SAI LIFE SCIENCES LTD Industry Peers by Asset Resilience Ratio

Compare SAI LIFE SCIENCES LTD's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Revvity Inc.
NYSE:RVTY
Diagnostics & Research 0.00%
SMO ClinPlus Co. Ltd.
SHE:301257
Diagnostics & Research 14.36%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for SAI LIFE SCIENCES LTD (2022–2025)

The table below shows the annual Asset Resilience Ratio data for SAI LIFE SCIENCES LTD.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 8.90% ₹2.81 Billion ₹31.60 Billion +1.82pp
2024-03-31 7.08% ₹1.61 Billion ₹22.75 Billion +0.90pp
2023-03-31 6.17% ₹1.35 Billion ₹21.87 Billion +1.55pp
2022-03-31 4.62% ₹1.00 Billion ₹21.64 Billion --
pp = percentage points